Trial intelligence / Profile preview

GSK2339345 in Chronic Idiopathic Cough

NCT01899768Phase 2Completed

Sponsor
GSK
Start
Nov 2013
Primary completion
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of GSK2339345 in chronic idiopathic cough (CIC), sponsored by GSK. Started Nov 2013; status: completed.

02

Drugs

GSK2339345
03

Conditions

chronic idiopathic cough (CIC)

Beyond the preview

Go deeper on NCT01899768.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01899768.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call